Tagungen und Workshops zum Thema Pharmakologie und Arzneimittelentwicklung

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Organisatoren können kostenlos ihre Konferenzankündigungen veröffentlichen.

ALLE LÄNDER

1.
 
5th Antiviral Drugs Research & Development Conference
ID
792205
Termin
01. Jun 2016 - 02. Jun 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We invite you to attend the 5th Antiviral Drugs Research & Development Conference, which will take place June 1-2, 2016 in San Diego, CA. This conference will bring together an exciting balance of industry and academia, where drug and vaccine designs in HIV, RSV, Hepatitis B/C, Influenza, etc. will be discussed. Top researchers will share their experiences with new inhibitory mechanisms, longer acting drugs, and strategies en route for cures. Delegates have the unique opportunity to network with colleagues from different sectors and gain fresh perspective on the research in antiviral drugs.
Kontakt
Kristen Starkey;     Tel.: [626-256-6405];     Email: infogtcbio@gtcbio.com
Themen
HIV, Zika, Antiviral Drugs
Verwandte Fachgebiete
2.
 
2nd Bugs & Drugs: Antibacterial Drug Discovery Conference (June 1-2, 2016, San Diego, CA)
ID
793736
Termin
01. Jun 2016 - 02. Jun 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We invite you to attend the 2nd Bugs & Drugs: Antibacterial Drug Discovery Conference, which will take place on June 1-2, 2016 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Bugs, Drugs, Antibacterial, Drug, Discovery
Verwandte Fachgebiete
3.
 
Infectious Diseases World Summit
ID
793745
Termin
01. Jun 2016 - 03. Jun 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
We invite you to attend the Infectious Diseases World Summit, which will take place on June 1-3, 2016 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Infectious, Diseases
Verwandte Fachgebiete
4.
 
CPHI 5th ANNUAL INNOPACK PHARMA CONFEX
ID
798733
Termin
02. Jun 2016 - 03. Jun 2016
Ort
Mumbai, Indien
Zusammenfassung
InnoPack is a global brand of CPhI Worldwide
Kontakt
Purvai Gupta;     Tel.: [91-22-61727077];     Email: purvai.gupta@ubm.com
Themen
Pharma Packaging, Consumer satisfaction, Consumer safety, Packaging experts, Packaging solutions, child-resistant and, user-friendly packaging, Serialization, Aggregation, Blister packaging, anti-counterfeiting, counterfeit products, RFIDs, , tamper, evident packs, labels, labeling regulation, Track and trace, US exports packaging, Europe markets, labeling packaging guidelines, prefilled syringes, Sustainability, flexible packaging, automation techniques, GLOBAL PACKAGING PERSPECTIVE, DRIVING SUSTAINABILITY, INNOVATIONs in packaging, printing innovations, aseptic packaging,
5.
 
14th Vaccines Research & Development Conference
ID
792171
Termin
02. Jun 2016 - 03. Jun 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Newly emerging infections have opened up dialogue about the need for novel treatments and government response to such infections. As we continue to search for solutions, we must review the lessons learned from research and industry response in order to overcome the current challenges. There are a number of exciting new developments including traditional vaccines and application of vaccines to new diseases, such as cancer vaccines. We will also discuss innovative efficacy trials and how to accelerate vaccine development. Join us as colleagues from industry and academia gather to discuss newly licensed vaccines, new vaccine technologies, RNA-based vaccines, and adjuvant discovery.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Vaccine, HIV, Zika
Verwandte Fachgebiete
6.
 
13th Anti-Infectives Partnering & Deal-Making Conference (June 2-3, 2016, San Diego, CA)
ID
793746
Termin
02. Jun 2016 - 03. Jun 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
GTCbio is proud to present the 13th Anti-Infectives Partnering & Deal-Making Conference, to be held on June 2-3, 2016 in San Diego, CA.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Anti-Infectives, Partnering, Deal-Making
Verwandte Fachgebiete
7.
 
3rd NovAliX Conference - Biophysics in Drug Discovery 2016
ID
788774
Termin
07. Jun 2016 - 10. Jun 2016
Ort
Straßburg, Frankreich
8.
 
ECI — Vaccine Technology VI
ID
738403
Termin
12. Jun 2016 - 17. Jun 2016
Ort
Cetraro, Calabria, Italien
Zusammenfassung
This conference series addresses technical and scientific issues in the development and manufacturing of vaccines. It will also discuss broader issues related to vaccine development and access that will be of interest to institutional and academic participants. Emphasis will be particularly placed on emerging diseases and developing world.
Kontakt
Arlene Conway;     Tel.: [212 514 6760];     Email: info@rngconfintl.org
Themen
Break through developments in vaccinology •Issues and case studies in process development •Formulating and delivering vaccines •Vaccine characterization/analytics •Therapeutic vaccines •Case studies •New challenges, new technologies in vaccine development. •One world, one health
9.
 
Vaccine Technology VI
ID
721699
Termin
12. Jun 2016 - 17. Jun 2016
Ort
Albufeira, Portugal
Kontakt
ARLENE CONWAY;     Tel.: [2125146760];     Email: info@engconfintl.org
Themen
In line with previous years, session topics will focus on all aspects of vaccine technology. This will include: •early antigen discovery and design •process development •analytics •clinical trials •commercialization.
10.
 
2016 Ross Prize in Molecular Medicine: Resolution of Inflammation
ID
797093
Beginn
13. Jun 2016
Ort
New York, Vereinigte Staaten
Zusammenfassung
The Ross Prize in Molecular Medicine was established in conjunction with the Feinstein Institute for Medical Research and Molecular Medicine. The Ross Prize recognizes biomedical scientists whose discoveries have changed the way medicine is practiced. The prize is awarded to midcareer scientists who have made a significant impact in the understanding of human disease pathogenesis and/or treatment and who hold significant promise for making even greater contributions to the general field of molecular medicine.

The 2016 Ross Prize in Molecular Medicine will be awarded to Dr. Charles N. Serhan for his important discoveries in identifying bioactive mediators and cellular pathways critical in the resolution of inflammatory diseases. With his instrumental finding that inflammation is an active process, Dr. Serhan has undertaken a multidisciplinary systems biology approach to elucidate the underlying molecular mechanisms of various inflammatory pathologies and develop novel compounds for treating these diseases.

Verwandte Fachgebiete
11.
 
17th Annual Drug Discovery Leaders Summit 2016
ID
774068
Termin
13. Jun 2016 - 14. Jun 2016
Ort
Berlin, Deutschland
Zusammenfassung
Oxford Global’s 17th Annual Drug Discovery Leaders Summit and our co-located 4th Annual Discovery Chemistry and Drug Design Congress is Europe’s leading Summit in the drug discovery and discovery chemistry field. Our prestigious Summit brings together prominent decision makers working at the forefront of research into target based discovery, phenotypic screening, medicinal chemistry and drug design.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Target Based Discovery, Screening and Assays: Enabling Technologies, Novel Therapeutic Modalities, Supporting Innovation: Data and Information Management, Discovery Chemistry: Latest Case Studies, Drug Design: Novel Approaches, Large Molecule Discovery Approaches
12.
 
Immunogenicity
ID
793267
Termin
13. Jun 2016 - 14. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
Immunogenicity of an antigen is frequently encountered in the context of vaccine development, an area of intense interest currently due to the emergence or re-emergence of infectious pathogens with the potential for worldwide spread. With the global vaccine market expected to reach $84.44 billion by 2022, now is the time engage with industry experts to addresses the real challenges with immunogenicity including assay assessment, the role of aggregation, the introduction of nanobodies and many more!
Kontakt
Anna Serazetdinova;     Tel.: [+44 20 7827 6093];     Email: aserazetdinova@smi-online.co.uk
Themen
immunology, immunogenicity, pathology, biosimilars, nanobodies, ADCs, aggregation
13.
 
6th RSC / SCI symposium on GPCRs in Medicinal Chemistry
ID
740213
Termin
13. Jun 2016 - 15. Jun 2016
Ort
Verona, Italien
Zusammenfassung
The key role of G-protein coupled receptors (GPCRs) in human disease underpins their importance to modern medicine. We are pleased to announce that Aptuit, Italy will support the sixth meeting in this series on GPCR drug discovery, which will combine cutting edge medicinal chemistry with innovative structural biology and novel drug design approaches.
14.
 
2016 Pharma CI Asia Conference & Exhibition
ID
807105
Termin
14. Jun 2016 - 15. Jun 2016
Ort
Hong Kong, China
Zusammenfassung
The 2016 Pharma CI Asia Conference (June 14-15, Hong Kong) is the industry's gold standard event for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Kontakt
Ross Frasier;     Email: ross@pharmaciconference.com
Themen
pharmaceutical, pharma, biopharma, competitive intelligence, business intelligence, medical device
15.
 
2PV2016 — 2nd Pharmacovigilance Conference 2016
ID
802870
Termin
14. Jun 2016 - 15. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
RecunnectLtd takes the pleasure to invite professionals involved in pharmacovigilance, risk assessment and management, clinical research, data analysis and related fields for a two day conference on Pharmacovigilance to enable them to gain a vantage point in the contemporary pharma industry by ingraining themselves with updates on regulatory trends in inspections of signal detection, post authorisation safety studies, optimal use of social media in pharmacovigilance, data mining technology, outsourcing Pharmacovigilance and strategic pharmacovigilance pre and post product life cycle.
Kontakt
Sarika Sareen;     Tel.: [2071129183];     Email: marketing@recunnect.net
Themen
risk assessment risk management clinical research data analysis pharma Conference Pharmacovigilance Pharmacogenomics/Drug Product Safety Drug Development, Information and Clinical Data Management Clinical Pharmacology Clinical Safety Periodical Safety update Report Risk Management, Research and Development Quality Assurance Patient Safety Safety Surveillance Outcomes Research Data Analysis Epidemiology Medical Affairs Regulatory Affairs and Compliance Information Technology Sales and Marketing
16.
 
WPC — 15th Annual World Preclinical Congress
ID
799429
Termin
14. Jun 2016 - 17. Jun 2016
Ort
Boston, MA, Vereinigte Staaten
Zusammenfassung
In recent years, the World Preclinical Congress (WPC) has turned into a key networking event for those involved in preclinical research. It features conferences, training seminars and short courses that cover the very latest in preclinical strategies and technologies, to enable better and faster decisions in drug discovery. WPC attracts a diverse, global audience, which include experts, as well as people who are new and eager to contribute to the field. Having chemists, biologists, pharmacologists, toxicologists, screening and formulation experts in attendance, creates an interesting cross-disciplinary environment for tackling challenges and sharing expertise. Now in its 15th year the event will continue to highlight ways to improve accuracy and efficiency in preclinical research, while bringing together the people and technologies to make it happen. As always, we ask those of you involved in preclinical work to try and help innovate traditional drug discovery by bringing along your ideas, showcasing new technologies, and fostering new collaborations. WPC is indeed the event “Where Preclinical Minds Meet Discovery Technologies” and we hope you can join this dynamic community to help shape the future of preclinical research!
Kontakt
Tel.: [7819725400];     Email: chi@healthtech.com
Themen
oncology, preclinical, toxicity, medical, chemistry, cell technology, drug discovery, drug development
Verwandte Fachgebiete
17.
 
Clinical Quality & Compliance Masterclass
ID
785637
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Wien, Österreich
Kontakt
Andrea Weber;     Email: andrea.weber@fleming.events
Themen
On the journey to clinical quality improvements at the site level, Inspection readiness for clinical & pharmacovigilance audits, Embracing QRM, QbD and RbM approaches to clinical quality, Third-party quality oversight
18.
 
Clinical Quality & Compliance Masterclass
ID
785627
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Amsterdam, Niederlande
Kontakt
Andrea Weber;     Email: andrea.weber@fleming.events
Themen
On the journey to clinical quality improvements at the site level, Inspection readiness for clinical & pharmacovigilance audits, Embracing QRM, QbD and RbM approaches to clinical quality, Third-party quality oversight
19.
 
ComplianceOnline Pharma Summit 2016 – Risk Control and Compliance
ID
796086
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
Pharmaceutical and biotechnology companies across the globe face unprecedented challenges in the dynamically changing clinical, regulatory and business landscape. Aging populations, chronic diseases, technology and treatment advances are expected to spur health sector growth in 2016. As we approach 2016, it is imperative that leaders in the pharma space understand the trends and shifts happening around them.Note:Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Pharma Summit 2016 - Risk control & Compliance, Biopharma summit 2016, Pharma Conferences, Pharma Events, Biotech Pharma Conclave
20.
 
The A to Z's of Microbial Control, Monitoring and Validation of Water Systems for Pharmaceuticals, Biologics, Medical Devices, Cosmetics, and Personal Care Products
ID
810943
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Newark, Vereinigte Staaten
Zusammenfassung
All facilities manufacturing pharmaceuticals, biologics, medical devices, cosmetics, and personal care products are likely to have high purity water systems. In spite of this purity, microorganisms can flourish within these systems and lead to undesirable contamination of facility processes and their products. Of all the individuals at the facility, it is site’s microbiologists who should understand the microorganisms in water systems and how best to monitor and control them. Sadly, this is often not the case due to the lack of familiarity with biofilm and its impact on water system sampling, testing, sanitization, and routine maintenance. This lack of understanding of microbial control often leads to poor system designs, poor system sampling, poor system maintenance and poor sanitization practices, and as a result, ongoing microbial problems with the water.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Pharmaceutical water systems seminar, water system compliance seminar, water system microbial control, water system microbial monitoring
21.
 
Design of Experiments (DOE) for Process and Product Optimization
ID
811019
Termin
16. Jun 2016 - 17. Jun 2016
Ort
Philadelphia, Vereinigte Staaten
Zusammenfassung
This course is designed to help scientists and engineers plan and conduct experiments and analyze the data to develop predictive models used to optimize processes and products and solve complex problems. DOE is an extremely efficient method to understand which variables (and interactions) affect key outcomes and allows the development of mathematical models used to optimize process and product performance. The models also provide an understanding of the impact of variability in controllable and uncontrollable factors on important responses. The concepts behind DOE are covered along with some effective types of screening experiments. Case studies will also be presented to illustrate the use of the methods.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
DOE, design of experiments, DOE techniques, data sets, key tools, good experimental practices, Experimental Design, Mathematical Models
22.
 
CMS3 — Advanced Topics on Cell Model Systems
ID
789607
Termin
20. Jun 2016 - 24. Jun 2016
Ort
Rom, Italien
Zusammenfassung
An intensive one week laboratory and lecturer school for PhD students and young researchers in the Eternal City Rome to facilitate an effective sharing and dissemination of new and innovative research ideas, strategies, focal points on cell model systems to promote pharmaceutical, pharmacogenomics, tissue engineering and computational research together with twelve outstanding scientists from different countries: Germany, Israel, Italy, Switzerland, United Kingdom. Fiftheen scientists of the Research Establishment of National Research Council (CNR) will impart practical exercises at laboratories on techniques in model membrane systems, optical microscopy, Raman and IR spectroscopy, nanostructures and biosensors, and dynamic molecular simulation. No other schools are present in Europe on this specific topic and mixing of theoretical and practical approaches.The school is certified as UNI EN ISO 9001:2000. The management respects the standard procedure and quality of international level. Participants must have a degree in either: Physics, Mathematics, Chemistry, Engineering, Biology or Medicine and a basic working knowledge of experimental research. Preference will be given to Ph.D. students and junior scientists under 35 and to those having not more then five years research experience. Applicants should send their current CV to the School Secretariat by email to: cms3.cnr@gmail.com , together with a formal signed letter of recommendation from a Professor who is aware of their work. The CV should include details of academic qualifications and a list of scientific publications as well as a short description of their current scientific research. Closing date for applications: May 6th, 2016. Registration fee:150 eur per person. It includes all academic sessions, course material, daily coffee-break and lunch (without drinks), social programme and certificate of completation.
Kontakt
Alfonsina Ramundo Orlando;     Tel.: [+39 (0)6 45488213];     Email: cms3.cnr@gmail.com
Themen
Cell model systems, Biophysics, Pharmacology, Imaging, Bio-sensors, Molecular Dynamic Simulations
Verwandte Fachgebiete
23.
 
Minnesota NMR Center 4th Annual Advanced Protein Workshop
ID
810480
Termin
20. Jun 2016 - 24. Jun 2016
Ort
Minneapolis, MN, Vereinigte Staaten
Zusammenfassung
This summer, the Minnesota NMR Center will offer once again, the annual "hands on" advanced NMR workshop, in which attendees will have the opportunity to learn methods applicable to both soluble and membrane-bound proteins. Not only will graduate students and postdoctoral associates familiarize themselves with state-of-the-art multidimensional techniques in solution NMR spectroscopy, but they will also be given an introduction to solid-state NMR methods and an opportunity to apply them to membrane-bound proteins.
Themen
NMR, NMR Spectroscopy, Workshop, Conference, solid-state, solution, membrane, protein, spectra, structure, biology, chemistry, physical, Minnesota, TopSpin, VNMRJ, nmrPipe, Sparky, Rosetta, sequential assignments, structure analysis, protein dynamics.
24.
 
Pharmacovigilance Europe 2016
ID
759906
Termin
21. Jun 2016 - 22. Jun 2016
Ort
London, Großbritannien
Zusammenfassung
The  Pharmacovigilance Europe 2016  conference will participants an opportunity and a platform to share experiences with the likeminded individuals in the field. The conference will also provide an insight into the complexities and challenges impacting public safety and risk management, focusing mainly on drugs, biologics and medical devices and the future of PV in the globalization era.
25.
 
5th Annual Drug Repositioning, Repurposing and Rescue Conference
ID
759948
Termin
21. Jun 2016 - 22. Jun 2016
Ort
Chicago, Vereinigte Staaten
26.
 
International Scientific Conference on Probiotics and Prebiotics - IPC2016
ID
745830
Termin
21. Jun 2016 - 23. Jun 2016
Ort
Budapest, Ungarn
Zusammenfassung
IPC2016 is the biggest scientific conference worldwide, solely focusing on probiotics and prebiotics for scientists, researchers, product developers, industry participants, pharmaceutical, medical, health and regulatory professionals as well as venture capitalists and investors.  The aim of the conference is to learn about recent advances, likely future developments and to exchange scientific ideas and experiences in our field – all within a unique environment. It is our intention to further confirm IPC as the leading scientific conference on probiotics and prebiotics. Every year the conference attracts up to  500 leading scientists,  opinion leaders, clinical study managers, medical doctors and dietitians from  more than 80 countries.
27.
 
2016 Canadian Pharma Market Research Conference
ID
807158
Termin
22. Jun 2016 - 23. Jun 2016
Ort
Toronto, Vereinigte Staaten
Zusammenfassung
The Canadian Pharma Market Research Conference (June 22-23, 2016, Toronto) is the premier gathering of senior-level pharmaceutical, biotechnology, medical device, and diagnostics executives in market research. This prestigious event brings together the industry’s top thought leaders and creates an environment of new ideas, relationships and perspectives. The Canadian Pharma Market Research Conference provides a focus on Canada, yet also frames the dialogue within the context of the global pharma industry. Attendees will walk away with invaluable information, integrated connections, and countless business opportunities.
Kontakt
Ross Frasier;     Email: ross@pharmaciconference.com
28.
 
Virus-Like Particle & Nano-Particle Vaccines VLPNPV 2016
ID
760045
Termin
22. Jun 2016 - 24. Jun 2016
Ort
Leiden, Niederlande
Zusammenfassung
Virus-like particles are supra-molecular assemblages incorporating key immunologic features of viruses which include repetitive surfaces, particulate structures with potential for induction of innate immunity through activation of pathogen-associated molecular-pattern recognition receptors. They carry no replicative genetic information and can be produced in heterologous expression systems at large scale. Virus-like particles thus represent a safe and effective vaccine platform with potential to induce potent B- and T-cell responses. In addition to being effective vaccines against the corresponding viruses from which they are derived, virus-like particles can also be used to present foreign epitopes to the immune system. This can be achieved by genetic fusion or chemical conjugation. This technological innovation has greatly broadened the scope of their use, from immunizing against microbial pathogens to immunotherapy for chronic diseases. Towards this end, virus-like particles have been used to induce auto-antibodies to disease-associated self-molecules involved in chronic diseases, such as hypertension and Alzheimer’s disease. The recognition of the potent immunogenicity and commercial potential for virus-like particles has greatly accelerated research and development activities. During the last decade, two prophylactic virus-like particle vaccines have been registered for human use, while another 12 vaccines entered clinical development. VLPNPV 2016 is the third meeting in this new series for international researchers working on Virus-Like Particles (VLPs) and Nano-Particle Vaccines (NPVs).
29.
 
FDA’s GMP Expectations for Phase I and First-in-Man Clinical Trials
ID
806263
Termin
23. Jun 2016 - 24. Jun 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Manufacturing an investigational product for the initial pilot clinical trials could pose a considerable logistical and financial challenge to developers. The first-in-man and pilot clinical trials are usually conducted in very small number of healthy participants with lower doses primarily to establish safety and hence do not need a significant amount of investigational material. The US FDA allows developers to test early stage investigational products under relaxed GMP requirements. The manufacturing requirements for early stage clinical trials are designed to assure adequate quality of the investigational product being tested without the excessive regulatory burden of full-scale GMP manufacturing. This workshop will present the current regulations, guidance documents and regulatory strategies available for manufacturing an early development stage product for Phase I and first-in-man clinical trials. Also discussed will be logistical issues with managing the supply of an early stage investigational product, and requirements for stability testing, storage and shipping, labeling, and documentations. Perspectives for different classes of products will be presented using case studies.
Kontakt
Peter Brown;     Tel.: [+1 410-501-5777];     Email: pbrown@fdamap.com
Themen
FDA GMP Regulations, FDA GMP Guidance, GMP for Phase 1, Good Manufacturing Practices, Phase 1 in Clinical Trials, Clinical Trials Regulations, Raw Materials Management
30.
 
Understanding the Statistical Considerations for Quantitative ICH Guidelines
ID
810940
Termin
23. Jun 2016 - 24. Jun 2016
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
This course is designed to introduce to individuals the understanding and interpretation of the statistical concepts with reference to certain quantitative ICH Guidelines that apply across laboratory (drug development) and clinical development (drug/device) procedures such as analytical methods in validation and acceptance criteria in calibration procedures, risk management and process monitoring as well as dealing with uncertainties and other relevant issues. It is not a course in statistics but introduces the participant to a hands on approach to the statistical techniques one uses, how they are applied and reasonably interpreted and understood. One will address the various challenges facing pharmaceutical and biotechnology companies when it comes to quantifying results in a meaningful interpretable manner through tabulations and graphical presentations.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Statistical considerations for quantitative ich guidelines training, quantitative measurement procedures, sensitivity of the sample size
31.
 
Designing and Sustaining New and Existing Product Stability Testing Program
ID
811005
Termin
23. Jun 2016 - 24. Jun 2016
Ort
San Francisco, Vereinigte Staaten
Zusammenfassung
New or existing modified drug Stability Testing Program's regulations/requirements stipulated by the FDA, 21 CFR or other regulations may sometimes creating an overwhelming situation based on the type of product that is being manufactured. Hence, some manufacturers of new drug products have made inadvertent mistakes in the design of their new drug stability testing program. Such mistakes may ultimately delay the new, existing or modified product IND or NDA application process due to the data that was presented to the FDA (i.e. Relevant aspects of the stability testing program requirement may have been omitted by the drug manufacturers). It is better to understand, follow and apply the full requirements of a new product stability testing requirement from the onset or to correct an existing stability testing program so as to avoid future pitfalls and delayed IND or NDA submission process by the FDA. Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
FDA's Drug Stability Testing Program, NDA submission, 21CFR 514.1(b)(5)(x) expectations, Analytical Testing Considerations
32.
 
Lyophilisation Europe
ID
799468
Termin
04. Jul 2016 - 05. Jul 2016
Ort
London, Großbritannien
Zusammenfassung
SMi is thrilled to announce the return of its 4th annual conference, Lyophilisation Europe, taking place on 4th and 5th July in London, UK. With the rising risk of contamination and the need for improved formulation methods of biological products, robust capabilities in lyophilisation and freeze drying methods have become critical for process efficiency and commercial success whilst maintaining drug quality and stability. Innovation and efficiency is requested at every level making Lyophilisation Europe 2016, the perfect platform to strengthen knowledge in key principles such as PAT and QbD, whilst staying at the forefront of technological breakthroughs to adapt to a competitive growing industry.
Kontakt
Teri Arri;     Tel.: [+442078276000];     Email: tarri@smi-online.co.uk
Themen
lyophilisation, quality by design, freeze drying, scale-up, validation, spray drying, Process Analytical Techniques, PAT, robustness, stability, delivery, optimisation, protein stabilisation, design strategies, maintenance, automatic loading and unloading, lyophilization, qbd, protein, optimization, aseptic, fill/finish, temperature, drying, powder, nucleation, sterilization, injectables, thaw, storage, crystallization, formulation, parenteral, lyophilization
33.
 
Pharmaceutical Supply Chain Integrity - Good Distribution Practices (GDP)
ID
811047
Termin
04. Jul 2016 - 05. Jul 2016
Ort
Shanghai, Vereinigte Staaten
Zusammenfassung
In China's latest public health scandal over the alleged illegal distribution of improperly stored vaccines that has reignited drug-safety concerns in China. According to state media, vaccines valued at almost $90 million have been distributed across the country. The health regulator says the vaccines were all produced by licensed manufacturers, but were stored and transported without proper refrigeration.Note: Use coupon code NB5SQH8N and get 10% off on registration.
Kontakt
Referral;     Tel.: [8887172436];     Email: referral@complianceonline.com
Themen
Good Distribution Practice, GDP with GMP, supply chain, risk management, PIC/S, GDP (GWP) regulations, GSP, GWP
34.
 
Allergies
ID
808670
Termin
06. Jul 2016 - 07. Jul 2016
Ort
London, Großbritannien
Zusammenfassung
Created with a top panel of industry thought leaders, SMi’s 3rd annual Allergies show returns to London on 6-7 July 2016, to capture expert insights by honing in on new pathways with novel vaccines and adjuvants, immunoassays for molecular diagnostics, paediatric allergies, personalised treatment, allergen specific immunotherapies, plus much more. Through strategic direction and regulatory guidance, the programme will strengthen knowledge in topics such as biomarker validation, and arm attendees with the key requirements and tools for successful trials and study outcomes. Featured speakers include: MHRA, Stallergenes Greer, HAL Allergy, Inflamax Research Inc , Allergy Therapeutics, Danone, Nestle, Nippon Medical School + many more! For details visit www.allergies-event.com
Kontakt
Teri Arri;     Tel.: [+442078276000];     Email: tarri@smi-online.co.uk
Themen
Allergy, Desensetisation, monoclonal antibody, vaccines, adjuvants, asthma, Pediatric, Paediatric, allergenoids, SLIT, SCIT, Dermatitus, policy, pathways, immunoglobulin, allergen, airway, reaction, allergic, clinical trials, immunotherapy, mite, food allergy, rhinitis, allergoid, respiratory, inflammation, dermatology, rash, dust mites, steroid, seroepidemilogical, biomark, vaccine, adjuvant, allergic disease, peanut allergy, milk allergy, diagnostic, pollution
Verwandte Fachgebiete
35.
 
RICT 2016 — Interfacing Chemical Biology and Drug Discovery
ID
788701
Termin
06. Jul 2016 - 09. Jul 2016
Ort
Caen, Frankreich
36.
 
Asia-Pacific Pharma Congress
ID
726968
Termin
14. Jul 2016 - 16. Jul 2016
Ort
Kuala Lumpur, Malaysia
Zusammenfassung
Asia Pharma-2016 is supported with related journals and their editorial board members which provide a chance of meeting them, along with experts in Medicine, Pharmacological sciences and Pharmaceutical sciences.Asia Pharma-2016 will be a great event where experts from universities, top Pharmaceutical industries, research centers and from the societies and association related to Pharmaceuticals. So, all are whole heartedly invited to be a part of this conference.
Kontakt
Robert Brown;     Tel.: [1-650-268-9744];     Email: asiapharma@pharmaceuticalconferences.com
Themen
IPR and Regulatory Affairs, Pharmacognosy, Pharmaceutics, Nanotechnology, Industrial Pharmacy, Pharmacology, Pharmaceutical Chemistry, Pharmaceutical Analysis, Pharmaceutical Microbiology, Pharmaceutical Biotechnology, Biochemistry, Hospital and Clinical Pharmacy.
37.
 
FASEB SRC: Translational Neuroimmunology: From Mechanisms to Therapeutics
ID
786148
Termin
24. Jul 2016 - 29. Jul 2016
Ort
Big Sky, Montana, Vereinigte Staaten
Zusammenfassung
This FASEB Science Research Conference will bring a greater understanding of the biochemical and molecular mechanisms underlying diseases associated with dysfunction in the neuroimmune system will undoubtedly facilitate the translational aspect of this field as novel therapeutic targets are moved towards human clinical trials. This will be facilitated by cutting-edge talks from scientists with international reputations on the topics of 1) CNS Metabolism and the Microbiome; 2) Inflammation in the Peripheral Nervous System; 3) Stem Cells and Neuroinflammation; 4) Neuroinflammatory Mechanisms of Demyelinating Diseases; 5) Immunity and Neurodegenerative Diseases; 6) Pre-clinical Studies for CNS Neuroinflammatory Diseases; 7) Neuroinflammation and Neurotrauma; 8) Neuroinflammation and Host Defense; and 9) The Many Faces of Microglia. In addition, this SRC will host a pre-meeting workshop entitled
Kontakt
FASEB SRC Staff;     Tel.: [3016347010];     Email: SRC@faseb.org
Verwandte Fachgebiete
38.
 
3rd Annual Advanced API Convention
ID
799333
Termin
25. Jul 2016 - 27. Jul 2016
Ort
Mumbai, Indien
Zusammenfassung
The 3rd Annual Advanced API Convention will be held in Mumbai between 25 – 27 July 2016. Intended as the foremost event for the API industry in India, the Advanced API Convention 2016 is an exciting event bringing the scientists of the world, Industry experts and key stakeholders under one platform. The Indian API market stands third in the world. At the same time, it relies heavily on China. This is a serious matter of concern which needs to be addressed to reduce dependency on China. CPhI always strives to voice out the concerns of Pharma professionals, and this year again we are delighted to bring you the 3rd Annual Advanced API Convention with an idea to encourage production of quality API’s, tackling problems right from R&D to Manufacturing phase.
Kontakt
Drashti Shah;     Tel.: [+91-22-61727381];     Email: drashti.shah@ubm.com
Themen
API, Convention, Conferences on API, QbD, Data Integrity, Scale-up, R & D, Elemental Impurities, Genotoxic impurities DoE, PAT, Q11, QRM, risk assessment, particle engineering, ICH Q8, ICH Q9, API Convention, API development, Flow chemistry, green chemistry, polymorph, crystallization, quality and yield, process design, equipment design, control strategy, GMP, CAPA, micronization, CQA’s, purifying, recrystallization, ICH M7, regulatory, process development, method development, impurities, manufacturing, implementation, quantitative distribution, consistent, design space, modelling tools, crystal size, distribution, Data Integrity
39.
 
CSDD-2016 — II International Conference on Clinical Sciences and Drug Discovery
ID
790723
Termin
27. Jul 2016 - 29. Jul 2016
Ort
Dundee, Scotland, Großbritannien
Zusammenfassung
United Scientific group had successfully completed its first conference International conference on Clinical Sciences and Drug Discovery, in Baltimore USA, during November 02-04, 2015 (CSDD-2015). With this enthusiasm and prodigious success, we are proudly announcing the second conference International conference on Clinical Sciences and Drug Discovery -2016, Dundee, Scotland during July 27-29, 2016 (CSDD-2016) with a theme Drug discovery and development to clinical trials. Our focus lies on the translation of academic research findings into industry-driven drug development, Features including a world-class program of invited speakers from industry and academia, oral and poster presentations from submitted abstracts maintaining the same level of talks. Throughout the course of the three-day conference, you will get an exclusive opportunity to network and be involved in inspiring and interesting discussions of scientists and researchers on Antimicrobials: Bacterial, Fungal, Viral, Protozoal, Antineoplastic, Endocrinology and Metabolism, Hematological, CNS & ANS, Cardio-Vascular System, Respiratory, Nano therapeutics, Computer Aided Drug Designing, Structural Biology and many more research topics. The organizing committee is confident that participants will benefit from the high value scientific program. We welcome all the researchers to join us for these 3 days of stimulating discussions, knowledge sharing and networking event.
Kontakt
CSDD-2016 Committee;     Tel.: [408-426-4833];     Email: drugdiscovery@uniscigroup.org
Themen
Infectious: Bacteria, Fungi, Viruses, Protozoa, Neoplastic: Cancers, Tumours, and Lymphomas, Endocrinologic and Metabolic, Hematological, CNS & ANS, Cardiovascular, Respiratory, Immunological, Nano-Bio Therapeutics, Computer Aided Drug Design, Structural Biology, Medicinal Chemistry & Imaging
40.
 
Innovations in Formulation and Drug Delivery 2016
ID
809482
Termin
28. Jul 2016 - 29. Jul 2016
Ort
Mumbai, Indien
Zusammenfassung
Of the total number of pharmaceutical manufacturers functioning in India, about 77% produce formulations and the remaining are into bulk drugs. At the same time, it is important for these manufacturers to produce quality drugs by complying with the regulatory authority guidelines. Considering this, CPhI brings you Innovations in Formulation and Drug Delivery, a two day event focused on improving drug performance and therapeutic impact through enabled formulations and more effective delivery methods
Kontakt
Sean Palanna;     Tel.: [91 22 6172 7072];     Email: sean.palanna@ubm.com
41.
 
7th Annual Global Pharma Summit
ID
803057
Termin
22. Aug 2016 - 24. Aug 2016
Ort
New Orleans, Vereinigte Staaten
Zusammenfassung
Pharma-2016 is a global conclave to discuss and learn about the sessions viz., Pharmaceutical Preformulation, Novel Drug Delivery Systems, Pharma Nanotechnology, Clinical Pharmacy, Pharmacology and Toxicology, Pharmacognosy and Phytochemistry, Pharmacy Practice, Medicinal Chemistry, Industrial Pharmacy, Regulatory Authorities, Bio and Chemo informatics, Market analysis and Business Opportunity.
42.
 
Drug Discovery & Therapy World Congress 2016 (4th in the Series)
ID
797101
Termin
22. Aug 2016 - 25. Aug 2016
Ort
Boston, MA, Vereinigte Staaten
Zusammenfassung
This unique international conference will provide a platform for all pharmaceutical scientists, internists and primary care physicians to discuss important international breakthroughs in drug discovery and new therapeutics. The focus of the conference will be on the interdisciplinary fields of drug discovery, drug therapy and translational medicine.
Kontakt
Hasina Habib;     Tel.: [+1-857-2398855];     Email: hasinahabib@eurekaconference.com
Themen
Academic CRO/Industrial collaborations in drug discovery Anti-Infectives Bioactive Lipids Biologics Clinical Trials and Regulatory Affairs Cancer Targeted Drug Delivery Cardiovascular Drug Discovery & Therapy Chemistry Combinatorial Chemistry CNS Drug Discovery & Therapy Diabetes and Obesity Drug Discovery & Therapy Drug Delivery & Targeting Drug Discovery in Preclinical Research Drug Metabolism Enabling Technologies Genomics Green Techniques for Medicinal Chemistry High-throughput Screening & Laboratory automation Hot Topics in Drug Targets Hot Topics in HIV Research Hot Topics in Medicinal Chemistry Hot Topics in Natural Products Inflammation and Immunology Innovative Drug Discovery and Nanotechnology In-silico Drug Design and in-silico screening Medical Imaging Nutraceutical Drug Discovery & Therapy Pharmaceutical Biotechnology Pharmaceutical Research & Development Pharmacogenomics Process Chemistry and Drug Manufacturing Protein and Peptide Sciences Proteomics & Bioinformatics Pulmonary Drug Discovery & Therapy Recent Advances in Patient Treatment and Care Recent Advances in Spectroscopy Regenerative Medicine Stereoselective Synthesis of Bioactive Compounds Structural Biology Systems Biology in Drug Design Traditional Chinese Medicine Translational Medicine Women’s Health Drug Discovery & Therapy
43.
 
10th Vaccine Congress
ID
800392
Termin
04. Sep 2016 - 07. Sep 2016
Ort
Amsterdam, Niederlande
44.
 
IIR-cryobio-workshop — IIR Workshop on Cold Applications in Life Sciences
ID
789076
Termin
08. Sep 2016 - 09. Sep 2016
Ort
Dresden, Deutschland
Zusammenfassung
Cell/tissue cryopreservation and cold storage are central challenges e.g. in biobanking. Freezing and cryoprocessing are becoming increasingly important as an essential production step in life sciences, too.
Kontakt
Dr. Gabriele Spoerl;     Tel.: [+49 351 4081 604];     Email: gabriele.spoerl@ilkdresden.de; CryoWorkshop2016@ilkdresden.de
Themen
Cell/tissue cryopreservation and storage challenges: advanced devices for cryopreservation and freeze-drying, cryobanking of biologicals, 3D-scaffolds / tissue engineering for medical and diagnostic applications, strategies with alternative cryoprotectants for tissues cryopreservation, industrial solutions in biomaterial processing. Freezing and storage of active agents for in-vitro and in-vivo applications: damage processes on active agents caused by cold application, process limitations and impact factors on product stability, process validation – analytics, monitoring and simulation of process and product loss, vitrification of cellular products without cryoprotectants, industrial freezing solutions - large scale and multi-product plant.
Verwandte Fachgebiete
45.
 
11th Drug Design & Medicinal Chemistry Conference
ID
806672
Termin
12. Sep 2016 - 13. Sep 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
We invite you to attend the 11th Drug Design & Medicinal Chemistry Conference, which will take place September 12-13, 2016 in Boston, MA. This meeting will provide a forum for scientists across multiple disciplines, from both industry and academia, to connect and share complementary perspectives. We will discuss emerging target classes, advances in antibody drug conjugates and other methods for targeted drug delivery, new approaches in flow chemistry, and much more. In addition to scientific presentations, we will have dedicated times for networking among delegates.
Kontakt
Kristen Starkey;     Tel.: [6262566405];     Email: infogtcbio@gtcbio.com
Themen
Drug Design, Medicinal Chemistry
46.
 
2016 Pharma CI USA Conference & Exhibition
ID
807082
Termin
13. Sep 2016 - 14. Sep 2016
Ort
Parsippany, NJ, Vereinigte Staaten
Zusammenfassung
The Best and Largest Assembly of Pharmaceutical Competitive Intelligence Executives! The 2016 Pharma CI USA Conference & Exhibition (Sept. 13-14, 2016, Parsippany, NJ) is the industry's gold standard for senior level pharma, biotech, and medical device professionals who seek the latest in competitive and business intelligence.
Kontakt
Ross Frasier;     Email: ross@pharmaciconference.com
Themen
pharma, pharmaceutical, biopharma, competitive intelligence, business intelligence
47.
 
BPA — BioPharm America™ 2016—9th Annual International Partnering Conference
ID
795815
Termin
13. Sep 2016 - 15. Sep 2016
Ort
Boston, Vereinigte Staaten
Zusammenfassung
Beginning its ninth year as an industry event, BioPharm America™ creates a robust exchange among hundreds of executives from venture capital firms, major pharmaceutical companies, academic institutions and biotechnology companies of every size from mature to startup. The event brings dealmakers from the life science ecosystem together to engage and de-risk the enormous task of drug development.
Themen
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance
48.
 
MUCOVAD 2016 — Mucosal Vaccines, Adjuvants & Delivery
ID
762177
Termin
14. Sep 2016 - 16. Sep 2016
Ort
Lausanne, Schweiz
Zusammenfassung
MUCOVAD 2016 will be an opportunity for researchers to hear updates on new developments in the area of mucosal vaccines and associated adjuvantation and delivery mechanisms/platforms
49.
 
4th Antivirals Congress
ID
801177
Termin
18. Sep 2016 - 21. Sep 2016
Ort
Barcelona - Sitges, Spanien
Zusammenfassung
The key objectives of these unique interdisciplinary conferences are:  To enable researchers from around the world to present important new findings;,  To highlight recent advances in drug and vaccine development, from basic science through clinical trials,  To publicize novel techniques that will speed the pace of research;,  To facilitate interdisciplinary collaborations, by providing opportunities for networking among laboratory scientists, clinicians and public health officials.. Meeting sessions will focus on new antiviral drugs, novel approaches to preventive and therapeutic vaccines, structural studies of viral proteins, antiviral drug resistance, emerging viruses and other topics.  The Congresses are sponsored by Antiviral Research, a journal for research on the prevention and treatment of viral diseases, now in its 35th year of publication. 
Verwandte Fachgebiete
50.
 
DOT — 14th Annual Discovery on Target
ID
806859
Termin
19. Sep 2016 - 22. Sep 2016
Ort
Boston, MA, Vereinigte Staaten
Zusammenfassung
Cambridge Healthtech Institute will host the 14th Annual Discovery on Target event this September 19-22, 2016 in Boston, MA. Spanning four days, the event showcases current and emerging “hot” targets for the pharmaceutical industry. Over 1,100+ attendees (from 26 countries) composed of scientists/technologists, executives, directors, and managers from biopharma, academic, and healthcare organizations participate annually. The 2016 event is comprised of 17 conference tracks, 1 training seminar, 5 symposia, 16 short courses, an exhibit hall of 50+ companies, 135+ posters, and dedicated networking sessions. Discovery on Target assembles an impressive group of 300+ distinguished speakers who look forward to sharing their knowledge, best practices, and expertise with all attendees.
Kontakt
Tel.: [7819725400];     Email: chi@healthtech.com
Themen
drug discovery, drug development, pharma, diseases, genomics, cancer
Verwandte Fachgebiete
51.
 
EYE — 4th Annual Targeting Ocular Disorders
ID
806803
Termin
20. Sep 2016 - 21. Sep 2016
Ort
Boston, MA, Vereinigte Staaten
Zusammenfassung
With its complex structure and the breadth of ocular disorders, the eye presents unique challenges to drug discovery. Cambridge Healthtech Institute’s fourth annual Targeting Ocular Disorders conference provides a platform to discuss novel targets and disease pathways, the latest drug delivery methods, and the most promising emerging therapies. A special focus will be on gene therapy, stem cell therapies, and treatments outside of the well-established anti-VEGF therapies. The event will cover a broad range of diseases including but not limited to glaucoma, wet and dry age‐related and diabetic macular degeneration, retinopathy and retinitis pigmentosa.
Kontakt
Tel.: [7819725400];     Email: chi@healthtech.com
Themen
ophthalmology, retinal diseases, gene therapy, ocular disorders, drug delivery, stem cells
Verwandte Fachgebiete
52.
 
ABK — PEGS Korea 2016: The Essential Protein Engineering Summit
ID
806813
Termin
20. Sep 2016 - 22. Sep 2016
Ort
Seoul, Republik Korea
Zusammenfassung
From the earlier regulatory successes of Adcetris® and Kadcyla® to the recent FDA approval of Blincyto®, to the current clinical successes of Opdivo® and Keytruda®, the industry is abuzz with excitement and new hope. The successes of antibody-drug conjugates, bispecific antibodies and immunotherapy drugs and combinations are opening new doors for biotech companies to discover and develop breakthrough remedies.
Kontakt
Tel.: [7819725400];     Email: chi@healthtech.com
Themen
protein engineering, antibody engineering, cancer immunotherapy
53.
 
Cancer Vaccines
ID
809618
Termin
21. Sep 2016 - 22. Sep 2016
Ort
London, Großbritannien
Zusammenfassung
Aimed at an audience of senior scientists and oncology specialists involved in targeted vaccines and drug research, Cancer Vaccines 2016 will provide a perfect platform to discuss pioneering clinical developments and the next generation of cancer immunotherapy. The 5th annual show will capture expert insight by honing in on new pathways with novel vaccines and immunotherapies, drug formulations, personalised treatment, immune check-point inhibitors, plus more
Kontakt
Teri Arri;     Tel.: [+442078276000];     Email: tarri@smi-online.co.uk
Themen
Cancer vaccines; combination cancer immunotherapy; CAR, T-Cell; Dendritic Cells; Epitopes, Cancer, vaccine, combination therapies, adjuvants, chimeric antigen receptors, cells, immunotherapies, tumour, efficacy, delivery, therapeutic vaccines, immune monitoring, PDL-1, CTLA4, monoclonal antibodies, conference, London; tumour, immune, genetic heterogeneity, angiogenic, immune-oncology, oncology, rna, immunogen, immune, personalized therapy, protein, biomarker, disease, novel pathway, molecular, vaccinology, cell-based, liposomes, dna, peptide, vaccine
Verwandte Fachgebiete
54.
 
12th Annual Quality in Pharma & Biotech
ID
811784
Termin
22. Sep 2016 - 23. Sep 2016
Ort
Wien, Österreich
Zusammenfassung
This event will exploit the importance of shifting from a culture of compliance to a culture of quality and improvement. Get updated on FDA- /EMA hot topics and how they are implemented by the industry. Explore how to make your processes more efficient and achieve a lean & cost-passive QA and QC.
Kontakt
Andrea Weber;     Tel.: [+421 257 272 145];     Email: andrea.weber@fleming.events
Themen
Culture of quality & change management, Lean quality, Quality metrics, GMP inspection observations, warning letters and consent decrees, ISO IDMP, Critical quality considerations for serialization, Data integrity, CMO quality oversight, Quality risk management, Technology transfer
55.
 
SIPCD 2016 — 4th Symposium on Innovative Polymers for Controlled Delivery
ID
800428
Termin
23. Sep 2016 - 26. Sep 2016
Ort
Suzhou, China
56.
 
Chemical biology approaches to assessing and modulating mitochondria
ID
776810
Termin
26. Sep 2016 - 27. Sep 2016
Ort
The Royal Society at Chicheley Hall, Buckinghamshi, Großbritannien
Zusammenfassung
Mitochondria are central to many current biomedical problems. In these, variations in chemical processes are critical, but progress in understanding these and in developing therapies has been hampered by lack of methods to measure and manipulate mitochondrial 'chemistry'. This meeting will explore the interface of chemical biology and mitochondrial studies to open up new avenues for research and therapeutic interventions.
Kontakt
Naomi Asantewa-Sechereh;     Tel.: [+442074512515];     Email: kavli.events@royalsociety.org
Themen
redox signalling, Reactive oxygen species (ROS), oxidative damage, mitochondria, mitochondrial therapies
Verwandte Fachgebiete
57.
 
14th Annual Pharma IT Congress
ID
787536
Termin
28. Sep 2016 - 29. Sep 2016
Ort
London, Großbritannien
Zusammenfassung
Oxford Global are proud to present the 14th Annual Pharmaceutical IT Congress, taking place on 28 – 29 September 2016 in London, UK. This highly established event will focus on exciting Big Data implementation case studies, novel research results in translational informatics, updates in data management for Real-World Evidence and novel IT solutions. The pharmaceutical IT industry represents a complex area of research that is under continuous pressure to develop novel solutions to improve its performance. Thanks to recent advancements in cloud computing solutions, Real-World Data and analytics, the industry is flourishing.
Kontakt
Guillaume Alonso;     Tel.: [+44 (0)1865 248 455];     Email: g.alonso@oxfordglobal.co.uk
Themen
Over 200 delegates representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic institutions Over 40 presentations and case studies focusing on the key developments in Big Data, Translational Informatics, Data Management for Real-World Evidence and IT Solutions Including 4 interactive streams: - Utilising Big Data In R&D - Translational Informatics - Data Management For Real-World Evidence - Novel IT Solutions
Verwandte Fachgebiete
58.
 
ICONAN 2016 — International Conference On Nanomedicine And Nanobiotechnology
ID
785178
Termin
28. Sep 2016 - 30. Sep 2016
Ort
Paris, Frankreich
Zusammenfassung
The target is to set up one of the most attractive international annual gatherings of experts from all around the world, in order for them to exchange about their latest research results and share their ideas.
Kontakt
ICONAN 2016 Organizing Committee;     Tel.: [0033781201182];     Email: iconan2016@premc.org
Themen
Targeted drug delivery and nanocarriers, Nanomedicine for cancer diagnosis & therapy, Biological & medical nanodevices and biosensors, Tissue engineering and regenerative nanomedicine, Toxicology and risk assessment of nanomedicine systems, Nano-Imaging for diagnosis, therapy and delivery, Bionanocatalysis and nanobisystems, Microfluidics in nanomedicine and nanobiology.
Verwandte Fachgebiete
59.
 
Biosimilars Europe
ID
809619
Termin
29. Sep 2016 - 30. Sep 2016
Ort
London, Großbritannien
Zusammenfassung
SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe , taking place on 29th & 30th September 2016 in Central London, UK. Gathering an audience of principle scientists and regulatory experts involved in biotechnology and compliance, Biosimilars Europe 2016 will provide a perfect platform to discuss global market developments and strategies to market access. Created with a top panel of industry thought leaders, this year's event will capture expert insight by honing in on the biosimilar product life-cycle from early stage developments, protein characterisation, and pricing & reimbursement; through to emerging markets and global developments. Join us this autumn to arm yourself with the key requirements and tools for successful market entry through strategic direction on commercialisation; insight into potential therapeutic areas; and guidance on product quality assessment (PQA) in biosimilar development. The notable speaker line-up includes: Boehringer Ingelhei, Merck, Lupin Ltd, Bristows, Austrian Agency for Health and Food Safety + many more!
Kontakt
Teri Arri;     Tel.: [+442078276000];     Email: tarri@smi-online.co.uk
Themen
biosimilars, biobetters, conference, regulatory, patent, us market, generics, pricing and reimbursement, market access, commercialisation, EU, global developments, emerging markets, pharmacovigilance, protein characterisation, analytical comparability, approval, immunogenicity, pqa, product quality assessment, comparative analysis, pricing and reimbursement, p&r, litigation, , European regulation, biogenerics, IP, intellectual property, data protection, supplementary protection certificate, payer
60.
 
European Pharmaceutical Market Access and Pricing & Reimbursement
ID
809033
Termin
10. Okt 2016 - 11. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
SMi Group’s 22nd annual European Pharmaceutical Market Access, Pricing and Reimbursement conference returns to London from 10-11 October 2016. The conference is one of the most established in the world, focusing on the changes in pricing and reimbursement and market access. Learn about new strategies, their strengths, weaknesses and future implications.
Kontakt
Fateja Begum;     Tel.: [+44 (0) 20 7827 6184];     Email: fbegum@smi-online.co.uk
Themen
pricing, market access, reimbursement, medicine, regulation, pharmacology,
61.
 
World ADC — World ADC San Diego
ID
803085
Termin
10. Okt 2016 - 13. Okt 2016
Ort
San Diego, Vereinigte Staaten
Zusammenfassung
Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. 
Kontakt
Jenny Barlow;     Tel.: [+1 212 537 5898];     Email: info@hansonwade.com
Themen
Develop Next Generation Clinically Transformative ADCs 2016 is set to be a momentous year for antibody-drug conjugates. Since the start of 2016 alone 3 new ADCs have entered human testing, joining the 54 ADCs already in clinical trials. The ADC industry is on the cusp of realizing the next therapeutic breakthrough. Rapidly diversifying payload, linker and antibody technologies and a surge of novel preclinical ADCs powering towards the clinic have all contributed to this gaining of momentum. Now in it’s 7th year, World ADC San Diego is the industry’s most definitive antibody drug conjugate forum. Its mission is to enable drug developers to realize the next generation of clinically successful ADC drugs. Covering the A-Z of ADCs, World ADC San Diego strikes the balance between distilling ground-breaking science with transformative research that will empower your programs tomorrow. This year, 650 prominent minds from 190 organisations will descend on World ADC San Diego giving you an unparalleled opportunity to foster new connections, catch-up with peers and progress business partnerships.
62.
 
The Structure of Clinical Trials and Experimental Therapeutics - University of Oxford
ID
749582
Termin
10. Okt 2016 - 14. Okt 2016
Ort
Oxford, Großbritannien
Kontakt
Course Administrator;     Tel.: [01865 286955];     Email: expther@conted.ox.ac.uk
Themen
pharmacology, drug development, clinical trials, experimental therapeutics, oxford
63.
 
Pharma Expo
ID
800948
Termin
12. Okt 2016 - 14. Okt 2016
Ort
Saint-Petersburg, Russische Föderation
Zusammenfassung
The 4th International exhibition of medicines, nutritional and dietary supplements Pharma will take place on 12-14 October 2016 in CEC EXPOFORUM in St. Petersburg.  International Exhibition of medicines, food and dietary supplements Pharma is important industry events for professionals in the medicine and pharmaceutical industry in the Northwest Russia.  The exhibition will be held as part of the St Petersburg International Health Forum.
64.
 
Training — Diabetes: An Overview
ID
791298
Beginn
13. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
This introductory course provides an overview of the causes, mechanisms and management of diabetes from both a clinical management and a drug development perspective. Our expert speaker will introduce the pathogenesis of the disease and discuss current prevention and treatment options as well as the complications associated with diabetes. The complex inter-relationship with dyslipidaemias, hypertension, obesity and subsequent cardiovascular risk will be examined in some detail.
Kontakt
Linda Merritt;     Tel.: [01727 809917];     Email: courses@healthcare-ed.com
Themen
Clinical presentation and classification, Pathophysiology of T2 diabetes, Treatment options, Micro and macrovascular complications, Prevention of type 2 diabetes – the evidence
65.
 
International Paediatric Pharmaceutical Care Masterclass
ID
800036
Termin
13. Okt 2016 - 15. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
This is a highly practical masterclass designed by the expert pharmaceutical team at Evelina Children’s Hospital London, part of Guy’s and St Thomas’ NHS Foundation Trust. The masterclass combines case studies, lectures, role plays and patient case reviews at hospital bed sides.
Verwandte Fachgebiete
66.
 
GCC Pharmacy Congress
ID
773567
Termin
17. Okt 2016 - 20. Okt 2016
Ort
Dubai, Vereinigte Arabische Emirate
Zusammenfassung
As the GCC countries healthcare moves towards a more patient-centric model, pharmacists are playing an increasingly important role in providing quality care to patients and they are vital members of the healthcare team. Pharmacists play an important role as leaders to improve healthcare outcomes, decrease cost, reduce patient safety risk, optimise medication management systems and align the pharmacy services with the management strategies that measure and reward quality performance. However, the continuing evolution of pharmacist role is tied to numerous challenges including collaboration with the different stakeholders in the medical community, learning about new technologies, remaining competitive in the marketplace, improving patient outcomes, maintaining productivity and more.
67.
 
WTCRF: Using Mixed Methods in Research
ID
807642
Beginn
19. Okt 2016
Ort
Edinburgh, Großbritannien
Zusammenfassung
Through a mixture of lectures and workshops, this one-day course will: - Discuss the long-standing “dichotomy” between quantitative and qualitative methods, and explore how these can be compatible when conducting mixed methods research - Explore the relevance of mixed methods designs for healthcare research and complex interventions - Explore the rationale behind “mixing” methods - Present the key taxonomies of mixed methods designs - Explore the epistemological underpinnings of mixed methods designs (pragmatism) - Provide a wider content for mixed methods research and link this to the Medical Research Council (MRC) Framework, and the principles of Implementation Science - Discuss the practicalities of designing and conducting mixed methods research as well as presenting related findings Date: Wednesday 19th October 2016 Time: 0930-1630 Venue: Seminar Room, Wellcome Trust Clinical research Facility, Western General Hospital, Edinburgh Course Fees: Student Rate: (valid matriculation card required) �40 NHS/Uni Early Bird Rate: (before 31 Aug 2016) �60 NHS/Uni Rate: (after 31 Aug 2016) �80 Industry: �160 For more information, or to book a place, please visit the WTCRF website www.crts.org.uk or contact us at wtcrf.education@ed.ac.uk or 44 (0)131 357 3355 Facebook: https://www.facebook.com/WTCRFEducationProgramme Twitter: @WTCRF_Education
Verwandte Fachgebiete
68.
 
RareX — RareX Rare Diseases Conference ft. ICORD
ID
803531
Termin
19. Okt 2016 - 22. Okt 2016
Ort
Kapstadt, Südafrika
Zusammenfassung
The purpose of this conference is to provide a global forum for all stakeholders within the Rare Disease field, both locally and abroad, to participate in open discussion, enhance models of best practice and share specialist knowledge around rare diseases and orphan drugs. Incorporating the annual International Conference on Rare Diseases and Orphan Drugs (ICORD) for 2016, RareX has an extended program, to incorporate patients, their families and caregivers as well as support groups and minority groups within the rare disease community.
Kontakt
Renee;     Tel.: [+27 (0) 21 683 2934];     Email: info@rarex.co.za
Themen
Rare Diseases, RareX, Orphan Drugs, Orphan diseases, ICORD, Rare Diseases South Africa
Verwandte Fachgebiete
69.
 
7th Euro-Global Summit on Toxicology and Applied Pharmacology
ID
804893
Termin
24. Okt 2016 - 26. Okt 2016
Ort
Rom, Italien
Zusammenfassung
Euro Toxicology 2016 enables the participants to “Connect, Collaborate and Perceive the Cutting Edge Research Works.” Eurotox aims to foster the spread of the newest advancements in the field of Toxicology and Pharmacology. It bestows a proficient platform to the students to traverse through the top notch research works by the leaders in the field.
Kontakt
Valentina Leyva;     Tel.: [702-508-5197];     Email: valentinaleyva10@gmail.com
Themen
toxicology, pharmacology, euro toxicology 2016, eurotox, pathology, toxicology conference in Europe, genetics, genetic toxicology, toxicity, clinical toxicology, poison, experimental toxicology, clinical toxicologists
70.
 
IMN — 8th Annual Immunogenicity and Bioassay Summit
ID
811185
Termin
26. Okt 2016 - 28. Okt 2016
Ort
Baltimore, MD, Vereinigte Staaten
Zusammenfassung
Following year-on-year success, CHI presents the Eighth Annual Immunogenicity and Bioassay Summit 2016: 3 conferences, FDA presenters plus 40+ additional presentations, 15+ interactive breakout round table and panel discussions, short courses, exhibit/poster hall, and networking opportunities with 250+ delegates. Immunogenicity Prediction & Control is designed to help investigators design and select non-immunogenic products for early-stage decision making, while Immunogenicity Assessment & Clinical Relevance and Optimizing Bioassays for Biologics will enable investigators to overcome the complexities of immunogenicity assessment and bioassays, and develop programs that ensure their products are safe and efficacious, and satisfy regulatory requirements.
Kontakt
Tel.: [781-972-5400];     Email: chi@healthtech.com
Themen
Immunogenicity, Clinical Relevance, Bioassays, Biologics
71.
 
Keystone Symposia: Translational Vaccinology for Global Health
ID
806812
Termin
26. Okt 2016 - 30. Okt 2016
Ort
London, Großbritannien
Zusammenfassung
The time required to launch new global health vaccines is too long and the late failure rate is unsustainably high. Key barriers include insufficient diversity and quality of preclinical concepts and candidates, immunobiological ignorance, and a lack of understanding of correlates or mechanisms of protection. Root causes include siloed science and linear thinking; poor integration across the discovery/development/delivery ecosystem; and slow entry and limited throughput in early human proof of concept testing. This Keystone Symposia meeting aims to bring together those pioneering novel, creative solutions to these problems of global vaccine discovery and development across the academic/biotech/product development partner/pharma spectrum.
Kontakt
Attendee Services;     Tel.: [1+ 970-262-1230 or 800-253-0685];     Email: info@keystonesymposia.org
Themen
Vaccines Immunology Infectious Diseases Global Health
Verwandte Fachgebiete
72.
 
Training — Immunotherapies: An Introductory Overview
ID
791296
Beginn
03. Nov 2016
Ort
London, Großbritannien
Zusammenfassung
This one-day programme provides an introduction to immunotherapies. Immunotherapies are an increasingly important treatment method for a wide range of diseases. This training is developed specifically for pharmaceutical industry personnel and provides a thorough foundation to the subject applicable across therapy areas. It is ideal for individuals with little understanding of immunotherapies and equally beneficial to those with existing basic knowledge enabling further insight to the subject through detailed presentations and discussion with Healthcare’s expert physician faculty.
Kontakt
Linda Merritt;     Tel.: [01727 809917];     Email: courses@healthcare-ed.com
Themen
The immune system – a guide, Introduction to immunotherapies, What goes wrong!, Examples in practice, The future
73.
 
BIO-Europe® 2016 - 22nd Annual International Partnering Conference
ID
796055
Termin
07. Nov 2016 - 09. Nov 2016
Ort
Köln, Deutschland
Zusammenfassung
BIO-Europe® is the preeminent partnering conference for the life sciences, bringing together international decision makers from the biotechnology, pharmaceutical and financial sectors, offering networking opportunities, workshop and panel participation, a high profile exhibition, and private, prescheduled one-to-one meetings.
Kontakt
Catharine Moreno Finan;     Tel.: [+49 89 2388 756-25];     Email: cmoreno@ebdgroup.com
Themen
partnering, business development, biotech, pharmaceutical, medical device, diagnostic, licensing, finance, life science
Verwandte Fachgebiete
74.
 
E&L Europe 2016 — Extractables & Leachables Europe 2016
ID
808762
Termin
08. Nov 2016 - 10. Nov 2016
Ort
Dublin, Irland
Zusammenfassung
The Smithers Rapra Extractables & Leachables conferences, held in both the US and in Europe, are the only two of their kind. Both events deliver a cutting edge analysis of testing techniques and high level insight into the global regulatory landscape, while allowing extensive time for debate and networking.
Kontakt
Emma Newton;     Tel.: [+44 (0) 1372 802016];     Email: enewton@smithers.com
Themen
extractable, leachable, pharmaceutical, packaging, pharmaceutical testing, medical devices, e-cigarettes, packaging testing, mass-spectrometry
75.
 
Gynaecological Oncology — An Update on Topical Issues within Gynaecology Oncology
ID
805575
Beginn
09. Nov 2016
Ort
South Kensington, London, Großbritannien
Kontakt
Conference Team;     Tel.: [020 7808 2921 / 4];     Email: conferenceteam@rmh.nhs.uk
Themen
Update in Gynaecology Oncology Surgery, Long term GI effects of cancer treatment; Genetics and BRCA testing in Gynaecology Oncology; Update in Gynaecology Clinical Oncology and Nurse led Clinics in Endometrial cancer, A Patient’s perspective, Supporting Women on aspects of motherhood and parenting, Update in Gynaecology Medical Oncology and Nurse led Chemotherapy Clinics, Sexuality post treatment for Gynaecological cancers, Summary and questions session.
Verwandte Fachgebiete
76.
 
APAMT2016 — Asia Pacific Association of Medical Toxicology 15th Scientific Congress
ID
788237
Termin
17. Nov 2016 - 20. Nov 2016
Ort
Singapore, Singapur
Zusammenfassung
The Toxicology Society of Singapore warmly invites all of you to join us in the 15th International Scientific Conference of the Asia Pacific Medical Association of Medical Toxicology (APAMT) 2016. This will be the first time that the APAMT conference is held in Singapore. APAMT 2016 promises an exciting experience as we bring together Clinical Toxicologists, Specialists in Poisons Information and researchers and scientists from all over the world, especially from the Asia Pacific to discuss their research, share experience and make new friends. The theme for this conference is “A Toxicologist’s Rendezvous – Meeting of the Disciplines”.

We look forward to welcoming you in Singapore in 2016!

Kontakt
Conference Secretariat;     Tel.: [+65 6570 6280];     Email: info@apamt2016.com
Themen
Toxicology Poison Analysis Chemical Environmental Toxinology
77.
 
28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
ID
773662
Termin
28. Nov 2016 - 02. Dez 2016
Ort
München, Deutschland
Zusammenfassung
It is our great pleasure to announce that the   28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics   will take place in Munich.  Hosted by the European Organisation for Research and Treatment of Cancer (EORTC), the National Cancer Institute (NCI) and the American Association for Cancer Research (AACR), the 2016 Symposium will bring together around 2000 academics, scientists and pharmaceutical industry representatives from across the globe to discuss innovations in drug development, target selection and the impact of new discoveries in molecular biology. As a one-of-a-kind Symposium at the forefront of drug development, it will enable participants to apply the latest findings and knowledge in their work and practice. This edition will also build on the success of the previous symposium which was widely praised for the quality of its programme, inspirational contributions and exclusive insights.
Verwandte Fachgebiete
78.
 
6th Munich Biomarker Conference - Clinical Practice and Targeted Therapies in Personalized Medicine
ID
789625
Termin
29. Nov 2016 - 30. Nov 2016
Ort
München, Deutschland
Zusammenfassung
We believe that the challenges of future medicine can only be solved by an interdisciplinary approach. On the one hand, biomarker-driven drug development follows common strategies, on the other hand, only joint efforts will transform the health care system. Therefore, the 6th Munich Biomarker Conference is open to various indications, including, but not limited to, oncology, respiratory diseases, immunology and infection, neurological disorders and orphan diseases.
Kontakt
BioM Biotech Cluster Development GmbH;     Tel.: [+49 (0) 89 / 89 96 79-0];     Email: info@bio-m.org
Themen
Biomarker discovery, validation and clinical use, biomarkers in drug discovery and development, innovative biomarker, technologies, cell-based and cell-free assays, liquid biopsy, biomarkers for immunotherapy, personalized medicine, companion diagnostics and patient selection, combination therapies, patient monitoring, evidence-based medicine
79.
 
MPMC — MENA Pharmaceutical Manufacturing Congress
ID
802830
Termin
29. Nov 2016 - 01. Dez 2016
Ort
Jeddah, Saudi-Arabien
Zusammenfassung
The MENA Pharmaceutical Manufacturing Congress, will set a unique platform by gathering the pioneers of local and international pharmaceutical companies; CEOs, plant managers, production managers, supply chain managers, quality assurance managers, regulators affairs managers, and engineers. In addition to the leading technology providers who will showcase the latest technologies and developments in pharmaceutical manufacturing. The congress will include case studies, presentations, and interactive panel discussions which will focus on issues such as the obstacles fronting the pharmaceutical industry, the integration between the different concerned entities, and the future of the industry in the region. The conference will also be accompanied by an exhibition that features the latest machinery and technologies used during the different pharmaceutical manufacturing stages, raw materials suppliers, and the regional manufacturers in the country. Join the MENA Pharmaceutical Manufacturing Congress, to gain knowledge and learn about the innovative strategies which are driving the growth of the pharmaceutical manufacturing in the MENA region, and leading the industry towards excellence.
Kontakt
Yarina;     Tel.: [+971 4 361 9616];     Email: info@pharmamanufacturingmena.com
Themen
Pharmaceutical, Manufacturing, Drug, MENA
80.
 
Vaccines-2017 — International Conference on Vaccines-2017
ID
811283
Termin
20. Feb 2017 - 22. Feb 2017
Ort
Baltimore, Vereinigte Staaten
Zusammenfassung
This scientific conference will bring an opportunity to share potential benefits and limitations of vaccines in preventing and control of infectious and non-infectious diseases thereby enhancing the quality and longevity of life.Vaccines 2017 mainly showcases comprehensive approaches in Vaccines and research, virology. vaccine conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations
Kontakt
James Martin;     Tel.: [1-302-231-6959];     Email: Vaccines@madrige.com
Themen
Vaccines, virology, Infectious and non infectious diseases, Therapeutic Medicines
Verwandte Fachgebiete
81.
 
MESMAP-3 — The Third Mediterranean Symposium on Medicinal and Aromatic Plants
ID
811603
Termin
13. Apr 2017 - 16. Apr 2017
Ort
Girne (Kyrenia), Cyprus, Türkei
Verwandte Fachgebiete
82.
 
Antibodies & Complement: Effector Functions, Therapies & Technologies
ID
781857
Termin
20. Jun 2017 - 23. Jun 2017
Ort
Albufeira, Portugal
Zusammenfassung
The antibody response and the complement system are major effector arms of the immune system. Both have been involved in a plethora of pathological conditions – including autoimmunity, allergy, infections and cancer- and regulate, mainly through their receptors (FcR and CR respectively) cell activation, migration, survival but also metabolism. As the portfolio of antibody- and complement-effector function grow, high-end technological solutions are developed and novel therapeutic applications are proposed.

This Zing conference will focus attention on key advances in both fields with the aim at fostering discussions between antibody experts and complement experts.

Verwandte Fachgebiete

Interessant...

You can advertise your event or services in this space.

Stand vom 30. Oktober 2092